Jie Peng

6PUBLICATIONS
1CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Solid tumoursPredictive and prognostic markersMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jun 12, 2025
Pretreatment CT-Based Machine Learning Radiomics Model Predicts Response in Inoperable Stage III NSCLC Treated with Concurrent Radiochemotherapy Plus PD-1 Inhibitors.

Ya Li, Min Zhang, Yong Hu

|May 26, 2025
Sintilimab + Nab-PP Combined with Recombinant Human Vascular Endothelial Inhibitor for Locally Advanced/Advanced and Recurrent Metastatic Squamous Non-Small Cell Lung Cancer: Study Protocol for a Single-Arm, Multi-Centre Phase II Clinical Study.

Junzhu Xu, Mi Meng, Sisi He

|Oct 04, 2024
Deep learning to estimate response of concurrent chemoradiotherapy in non-small-cell lung carcinoma.

Jie Peng, Xudong Zhang, Yong Hu

|Jan 23, 2024
A novel sub-regional radiomics model to predict immunotherapy response in non-small cell lung carcinoma.

Jie Peng, Dan Zou, Xudong Zhang

|Mar 12, 2020
Deep neural network classification based on somatic mutations potentially predicts clinical benefit of immune checkpoint blockade in lung adenocarcinoma.

Jie Peng, Dan Zou, Wuxing Gong

|Oct 13, 2019
A gut microbiota score predicting acute graft-versus-host disease following myeloablative allogeneic hematopoietic stem cell transplantation.

Lijie Han, Ke Zhao, Yuanyuan Li

Pageof 1

Frequent Collaborators

1 joint publications

Jian-Guo Zhou